NCT05990465 2026-02-23LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell MalignanciesMedical College of WisconsinPhase 1 Recruiting12 enrolled
NCT05529069 2025-10-24Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) PatientsM.D. Anderson Cancer CenterPhase 2 Recruiting30 enrolled